A detailed history of Regentatlantic Capital LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Regentatlantic Capital LLC holds 8,897 shares of MRVI stock, worth $45,641. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,897
Previous 10,246 13.17%
Holding current value
$45,641
Previous $291,000 21.99%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$20.6 - $30.37 $27,789 - $40,969
-1,349 Reduced 13.17%
8,897 $227,000
Q1 2022

May 02, 2022

SELL
$24.46 - $40.92 $3,130 - $5,237
-128 Reduced 1.23%
10,246 $361,000
Q4 2021

Jan 27, 2022

BUY
$35.0 - $45.94 $139,615 - $183,254
3,989 Added 62.47%
10,374 $435,000
Q3 2021

Nov 15, 2021

BUY
$36.8 - $60.62 $234,967 - $387,058
6,385 New
6,385 $313,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $675M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Regentatlantic Capital LLC Portfolio

Follow Regentatlantic Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.